Clinical Trial Update: Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating D-cycloserine to help smokers switch to an e-cigarette by accelerating learning of adaptive habits; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Rose Research Center, LLC | Conditions: Smoking Cessation, Harm Reduction | Phase 2 | Status: COMPLETED